Clinical Trial

A Study to Compare JL14002 to Lucentis® in Subjects With Wet Age-related Macular Degeneration (wAMD)

Completed Phase 3
View on ClinicalTrials.gov →
Summary
This is a randomised, double-masked, parallel group, multicentre study to evaluate the efficacy and safety of JL14002 compared to Lucentis® in subjects with wAMD.
Trial Details
NCT Number NCT07389577
Lead Sponsor Jecho Biopharmaceuticals Co., Ltd.
Conditions Wet Age-related Macular Degeneration
Enrollment 443 participants
Start Date 2022-03-01
Primary Completion 2023-12-20 (estimated)
Study Completion 2024-09-23 (estimated)
Updated on ClinicalTrials.gov 2026-02-05